Skip to main content
. 2022 Jan 10;23:15. doi: 10.1186/s13059-021-02589-4

Fig. 4.

Fig. 4

Patients with pre-existing cardiomyopathy show an increased mortality rate. A Kaplan-Meier curve of COVID19 patients with pre-existing cardiomyopathy (N = 43), patients with other pre-existing cardiovascular diseases (N = 624), and patients without cardiovascular diseases (N = 3269). P values are from Cox proportional-hazards models, controlling for differences in the demographics and non-cardiovascular conditions between the groups. B Kaplan-Meier curve of COVID19 patients with pre-existing cardiomyopathy (N = 43) and a cohort of propensity score-matched patients with other pre-existing cardiovascular diseases (N = 344). P values are from a log-rank test. C Kaplan-Meier curve of COVID-19-negative patients with pre-existing cardiomyopathy (N = 2250) and a cohort of propensity score-matched patients with other pre-existing cardiovascular diseases (N = 18,000). P values are from a log-rank test